Filter Search


Europe


Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130a Paragraph 8 Sgb V With The Active Ingredient Metoprolol In The Dosage Form Ret And The Effective Strength 50mg. 2026-04-22
Germany Lot 4: Bmz/ Bma/ Nea voluntary Prior Information 2026-04-22
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V In The Active Ingredient Combination Risedronic Acid+ca+colecalciferol With The Atc Code: M05bb04. 2026-04-22
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Clonazepam Tab. 2026-04-22
Netherlands 3d Metal Printers 2026-04-22
Germany Openhouse Procedure health Days/screenings 2026-04-22
Germany Vp13: Escalators open Procedure 2026-04-22
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Octreotide In The Dosage Forms Pls And Trs. 2026-04-22
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130a Paragraph 8 Sgb V With The Active Ingredient Omeprazole As An Otc Medicine. 2026-04-22
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph. 8 Sgb V On The Active Ingredient Tocilizumab (exclusively Infusion Solution Concentrate), Atc L04ac07 For The Period December 1st, 2025 November 30th, 2027 2026-04-22
Whats app